Drug therapy for hereditary cancers
Drug therapy for hereditary cancers
About this item
Full title
Author / Creator
Publisher
Poland: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Poland: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Tumors arising in patients with hereditary cancer syndromes may have distinct drug sensitivity as compared to their sporadic counterparts. Breast and ovarian neoplasms from BRCA1 or BRCA2 mutation carriers are characterized by deficient homologous recombination (HR) of DNA, that makes them particularly sensitive to platinum compounds or inhibitors...
Alternative Titles
Full title
Drug therapy for hereditary cancers
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_5347c4ac742346fdb95e60586baad579
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5347c4ac742346fdb95e60586baad579
Other Identifiers
ISSN
1897-4287,1731-2302
E-ISSN
1897-4287
DOI
10.1186/1897-4287-9-5
